Master Alliance Provisions Guide
(MAPGuideⓇ)

The MAPGuideⓇ platform is a tool for accessing and exploring analysis of global health agreements, particularly those that seek to ensure equitable access to medical products.

Agreement Provision Database

What Is It?

The MAPGuideⓇ provision database has been built from our analysis of key provisions from global health agreements. 

Our analysis is organized into “issues, which are key areas of consideration for rapidly developing and negotiating agreements with the aim of achieving equitable access.

Please note that the database is not optimized for mobile viewing.

How Do I Use It?

The database is searchable by Issue and by Agreement Feature (type of party, agreement type, stage of development, product type).

Use the menu above to explore the search options or access the agreement index. 

You can also take a look at our quick tutorials to help you get started.

How Can I Contribute?

We welcome submissions of agreements or provisions that include examples of approaches to equitable access obligations. Content can be redacted and/or anonymized as required.

You can submit new content using the button below, or contact us to discuss a potential submission.

Submit content

Resources

Equitable Access Toolkit

Guidance for product R&D funders seeking to translate equitable access policies into enforceable agreement provisions

Equitable Access Toolkit

Our Equitable Access Toolkit provides insights into how equitable access policies can be translated into provisions that result in meaningful and measurable impact. You can read more about why we created the Toolkit here.

The toolkit presents best practice considerations for developing and negotiating product R&D funding agreements, supported by examples from our provision database
Open the Toolkit

Equitable Access Policies

Examples of policies from R&D funders, product development partnerships and academia

Equitable Access Policies

Our Equitable Access Policies page provides an overview of, and links to, equitable access policies and related resources published by a range of product development funders, product development partnerships (PDPs), and academic institutions.
Go to Policies

Commentaries

Perspectives on agreement provisions and their impact on who has timely access to critical medical products.

Commentaries

Our Commentaries provide analysis of the role of policies and agreement provisions in achieving equitable access to medical products. The commentaries include GHIAA's perspective on the impact of agreement language on topical issues in the field of global health, such as access to COVID-19 technologies, publicly funded innovations, and the pandemic accord.
Find out more

Equitable Access Toolkit

Guidance for product R&D funders seeking to translate equitable access policies into enforceable agreement provisions

Equitable Access Toolkit

Our Equitable Access Toolkit provides insights into how equitable access policies can be translated into provisions that result in meaningful and measurable impact. You can read more about why we created the Toolkit here.

The toolkit presents best practice considerations for developing and negotiating product R&D funding agreements, supported by examples from our provision database
Open the Toolkit

Equitable Access Policies

Examples of policies from R&D funders, product development partnerships and academia

Equitable Access Policies

Our Equitable Access Policies page provides an overview of, and links to, equitable access policies and related resources published by a range of product development funders, product development partnerships (PDPs), and academic institutions.
Go to Policies

Commentaries

Perspectives on agreement provisions and their impact on who has timely access to critical medical products.

Commentaries

Our Commentaries provide analysis of the role of policies and agreement provisions in achieving equitable access to medical products. The commentaries include GHIAA's perspective on the impact of agreement language on topical issues in the field of global health, such as access to COVID-19 technologies, publicly funded innovations, and the pandemic accord.
Find out more